Bruehlman Ronald E
SEC CIK 1604076 · EDGAR
BoughtSold
Most active insiders at GDRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FRANCISCO PARTNERS IV, L.P. | 10% | — | $9.68M |
| 2 | SEA VII Management, LLC | 10% | — | $95.1K |
| 3 | Fengler Justin | See Remarks | — | — |
| 4 | Chan Thomas (TC) | CAO | — | — |
| 5 | Barnes Wendy Lynn | See Remarks, Dir | — | — |
| 6 | Nabiey Romin | CAO | — | — |
| 7 | Hirsch Douglas Joseph | Dir | — | — |
| 8 | Bezdek Trevor | Dir | — | — |
| 9 | McGinnis Christopher A | See Remarks | — | — |
| 10 | Bruehlman Ronald E | Dir | — | — |
Transactions 24
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 20:30 | 2026-06-16 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +73.4K | 207.4K | +55% | $0 | |
| 2026-05-29 17:58 | 2026-05-27 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +4,642 | 133.9K | +4% | $0 | |
| 2026-02-10 | 2026-02-08 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +16.3K | 50.9K | +47% | $0 | |
| 2026-02-10 | 2026-02-08 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $187.49 | -6,801 | 44.1K | -13% | -$1.28M | |
| 2026-01-05 | 2026-01-01 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +18.3K | 129.3K | +16% | $0 | |
| D | 2025-11-10 | 2025-11-08 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | M - OptEx | — | +21.7K | 111.0K | +24% | — |
| 2025-06-04 | 2025-06-03 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +57.0K | 89.3K | +177% | $0 | |
| 2025-02-12 | 2025-02-10 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $206.97 | -907 | 34.6K | -3% | -$187.7K | |
| D | 2025-01-30 | 2025-01-28 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +6,286 | 37.7K | +20% | $0 |
| D | 2025-01-30 | 2025-01-28 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $203.43 | -2,201 | 35.5K | -6% | -$447.7K |
| 2025-01-03 | 2025-01-01 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +10.7K | 32.3K | +49% | $0 | |
| DM | 2024-11-12 | 2024-11-08 | GDRX | GoodRx Holdings, Inc. | Bruehlman Ronald E | Dir | A - Grant | $0.00 | +21.6K | 21.6K | New | $0 |
| M | 2024-02-13 | 2024-02-09+ | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $218.20 | -1,940 | 32.3K | -6% | -$423.3K |
| D | 2024-02-08 | 2024-02-06 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +24.1K | 43.8K | +123% | $0 |
| D | 2024-02-08 | 2024-02-06 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $215.41 | -10.5K | 33.3K | -24% | -$2.26M |
| 2023-08-07 | 2023-08-03 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $216.29 | -2,588 | 19.7K | -12% | -$559.8K | |
| M | 2023-02-13 | 2023-02-09+ | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $226.86 | -1,331 | 22.3K | -6% | -$302.0K |
| 2022-08-05 | 2022-08-03 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $233.21 | -2,588 | 23.6K | -10% | -$603.5K | |
| 2022-02-17 | 2021-10-25 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | S - Sale | $256.93 | -4 | 26.2K | -0.0% | -$1,028 | |
| 2022-02-17 | 2021-09-23 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | P - Purchase | $262.82 | +4 | 26.2K | +0.0% | +$1,051 | |
| D | 2022-02-14 | 2021-07-20 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | P - Purchase | $245.32 | +13 | 20.4K | +0.1% | +$3,189 |
| D | 2022-02-14 | 2022-02-10 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | A - Grant | $0.00 | +5,869 | 26.2K | +29% | $0 |
| 2022-02-11 | 2022-02-09 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $255.57 | -705 | 20.3K | -3% | -$180.2K | |
| 2021-08-05 | 2021-08-03 | IQV | IQVIA | Bruehlman Ronald E | See Remarks | F - Tax | $0.00 | -2,391 | 21.0K | -10% | $0 |
Purchase Sale Sale after option exercise All abbreviations